FIELD: medicine.
SUBSTANCE: invention relates to field of medicine and deals with improvements of meningococcus outer membrane vesicles (OMV), directed against particular epidemic strains, which cam be extremely efficiently used for struggle with local outbreaks of the disease. Essence of method includes mixture of (OMV), from 2 serortypes of meningococci P1.7b,4 and PI.7,16, set for meningitis treatment and method of introduction of OMV-based composition.
EFFECT: elaboration of vaccine for mass immunisation.
12 cl
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINES FOR SEROGROUP X MENINGOCOCCUS | 2013 |
|
RU2644340C2 |
| MENINGOCOCCAL fHBP POLYPEPTIDES | 2009 |
|
RU2475496C2 |
| MENINGOCOCCAL fHBP POLYPEPTIDES | 2012 |
|
RU2567003C2 |
| KIT FOR PREPARING IMMUNOGENIC COMPOSITION FOR SEROGROUP B Neisseria meningitidis | 2008 |
|
RU2498815C2 |
| COMBINATIONS CONTAINING SEROTYPE 14 PNEUMOCOCCAL SACCHARIDE | 2010 |
|
RU2549438C2 |
| LIQUID VACCINE FOR MULTIPLE SEROGROUPS OF MENINGOCOCCUS | 2009 |
|
RU2595845C2 |
| LIQUID VACCINES FOR MULTIPLE MENINGOCOCCAL SEROGROUPS | 2004 |
|
RU2378010C2 |
| VACCINES CONTAINING ALUMINIUM ADJUVANTS AND HISTIDIN | 2007 |
|
RU2432173C2 |
| HYPO- AND HYPERACETILATED MENINGOCOCCAL CAPSULAR SACCHARIDES | 2004 |
|
RU2362784C2 |
| MULTIPLE VERSIONS OF MENINGOCOCCAL PROTEIN NMB 1870 | 2003 |
|
RU2336091C2 |
